This week, regulators, dealmakers, and manufacturers converged on the same demand: greater accountability and resilience across drug development and manufacturing.…
Browsing: Pharmaceutical
China-based biopharma is evaluating its skin-restricted pan-JAK inhibitor, LNK01004 ointment, in a Phase II study for vitiligo, aiming to deliver…
TAIPEI, July 9, 2026 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) today announced the appointment of Brian J. Groch as…
As pharmaceutical leaders navigate IRA price negotiation, significant uncertainties remain about how policies will unfold. In this discussion, four regulatory…
BOSTON, July 07, 2026 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people…
Amylyx Pharmaceuticals (AMLX) has just been removed from several Russell equity indexes, a technical event that can prompt index tracking…
CSPC Pharmaceutical Group (SEHK:1093) is back in focus after a new collaboration, option and license agreement with AstraZeneca to develop…
Maintained ‘AA’ Grade for Second Consecutive Year Bukwang Pharmaceuticals announced on July 6 that it received an ‘AA’ grade in…
EnglishEnglishSelect market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems…
Lupin Ltd (ISIN INE326A01037) is a large pharmaceutical company headquartered in India that has become a significant global supplier of…